Generic Series An Introduction To The Canadian Generics Market

Document Sample
Generic Series An Introduction To The Canadian Generics Market Powered By Docstoc
More information from

Generic Series: An Introduction To The Canadian Generics Market -
Key Trends And Leading Companies Shaping The Market

Description:    The Canadian pharmaceutical market is the 8th largest globally and as such represents an
                important market for generics manufacturers.

                Although historically dominated by domestic generics companies, mergers and acquisitions over the
                last five years have increased the dominance of foreign players.

                Scope of this title:

                Overview of the size of the Canadian generics market

                Assessment of the key drivers and resistors affecting the Canadian generics market

                Profiles of the leading companies in the Canadian generics market

                Highlights of this title:

                The Canadian generics sector has recorded steady growth over recent years to become one of the
                more mature generics markets compared to the other major pharmaceutical markets. However a
                number of issues impacting the market make it a very different operating environment compared to
                the neighboring US market. Domestic generics manufacturers have historically had an advantage in
                this market however overseas players have increased there presence through acquisitions over
                recent years to enable them to benefit from the same advantages.

                Reasons to order your copy:

                Assess the size of the Canadian generics market relative to the other major markets globally

                Examine the growth drivers and resistors that are shaping this significant generics market

                Benchmark the key companies operating in the Canadian generics market

Contents:       Chapter 1.

                 Executive summary 4
                 Scope of the report 4
                 Key findings 5

                Chapter 2.

                 Overview of the canadian generics market 8
                 Scope 8
                 Introduction to the Canadian pharmaceutical market 8
                 Canadas pharmaceutical market has experienced double-digit prescription sales growth since 2002
                 The generics market represents a significant proportion of both prescription volume and total
                market value 11
                 Key issues affecting the Canadian generics market 14
                 The establishment of the Canadian generics market 14
                 Differences in healthcare environment and cost-containment initiatives between provinces increase
                the complexity of operating in the Canadian generics market 14
                 Key drivers and resistors impacting the Canadian Generics Market 15
                 A range of resistors impact generic market growth 16
                 Market exclusivity extension: generics companies must wait longer for generic entry 16
 Pseudo-generics: inhibiting real generic growth 17
 A number of drivers are helping to drive generics market growth in Canada 18
 Compulsory licensing for export to developing countries: theoretically an opportunity for generic
growth, but in practice proving complex 18
 High cost of generic drugs in Canada relative to rest of world favors generic manufacturers 19
 Early working exception policy accelerating speed to market for generic drugs in Canada 21
 Biosimilars - a potential new industry 21

Chapter 3.

Key generics companies operating in the canadian market 23
Introduction 23
Apotex - the largest Canadian-owned generics manufacturer in Canada 24
Overview 24
Company strategy 24
Speed to market 25
Patent challenges 25
Diversification into biosimilars 26
Access to niche markets via Cangene 26
Diversification into proprietary drugs 26
Apotexs domestic position 27
Company outlook 27
Teva 28
Overview 28
Company strategy 28
First to file patent challenges 28
Good distribution infrastructure in Canada 29
Proprietary drug development 29
Expansion into biosimilar market 29
Company outlook 30
Merck KGaA (Merck Serono) 30
Overview 30
Company strategy 30
Growing pipeline 31
Diversification into more specialist areas 31
Geographic growth by M&A 32
Company outlook 32
ratiopharm 32
Overview 32
Company strategy 33
Geographical expansion 33
Expansion into controlled release delivery market 33
Expansion into biosimilar market 34
Pharmascience - the second largest Canadian-owned generics manufacturer 34
Overview 34
Company strategy 35
Pipeline expansion 35
Manufacturing facilities 35
International ventures 35
Diversification into OTC business 35
Company outlook 36
Other generic pharmaceutical companies 36
Cobalt Pharma 36
Stiefel Laboratories 36
Axcan Pharma 37
Mayne Pharma 37
Ranbaxy 37
Taro Pharmaceuticals 37
Sandoz (Novartis) 38

Chapter 4.

            List of Tables
            Table 1: Estimates of Canadian market size, 2003 and 2005 10
            Table 2: Comparison of drug sales per capita

            List of Figures
            Figure 1: Ethical sales in Canada 2003-05: $5 billion increase in prescription sales 9
            Figure 2: Total market sales and generic sector sales 2002-05 12
            Figure 3: The generic market share as a percentage of total pharmaceutical sales varies across
            markets 13
            Figure 4: Key issues in Canadian generic industry, 2007 16
            Figure 5: Purpose of launching pseudo-generics/licensed generics globally 17

Ordering:   Order Online -

            Order by Fax - using the form below

            Order by Post - print the order form below and sent to

                         Research and Markets,
                         Guinness Centre,
                         Taylors Lane,
                         Dublin 8,
                                                           Page 1 of 2

Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-
1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

Order Information
Please verify that the product information is correct.

               Product Name:           Generic Series: An Introduction To The Canadian Generics Market - Key
                                       Trends And Leading Companies Shaping The Market
               Web Address:  
               Office Code:            OCIEFKPLOOT

Product Format
Please select the product format and quantity you require:


               Electronic:               EURO €4,066.00

Contact Information
Please enter all the information below in BLOCK CAPITALS

      Title:                  Mr              Mrs            Dr          Miss             Ms         Prof

      First Name:                                                 Last Name:

      Email Address: *

      Job Title:




      Postal / Zip Code:


      Phone Number:

      Fax Number:

     * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)
                                                              Page 2 of 2

Payment Information
Please indicate the payment method you would like to use by selecting the appropriate box.

          Pay by credit card:                     American Express

                                                  Diners Club

                                                  Master Card

                                           Cardholder Name

                                           Expiry Date

                                           Card Number

                                           CVV Number

                                           Issue Date
                                           (for Diners Club only)

          Pay by check:                    Please post the check, accompanied by this form, to:

                                           Research and Markets,
                                           Guinness Center,
                                           Taylors Lane,
                                           Dublin 8,

                                           Please transfer funds to:
          Pay by wire transfer:
                                           Account number                   833 130 83
                                           Sort code                        98-53-30
                                           Swift code                       ULSBIE2D
                                           IBAN number                      IE78ULSB98533083313083
                                           Bank Address                 Ulster Bank,
                                                                        27-35 Main Street,
                                                                        Co. Dublin,

     If you have a Marketing Code please enter it below:

           Marketing Code:

      Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at

                                              Please fax this form to:
                                  (646) 607-1907 or (646) 964-6609 - From USA
                          +353 1 481 1716 or +353 1 653 1571 - From Rest of World

gregoria gregoria